PubMed

Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study.

Herder C, Brunner EJ, Rathmann W, Strassburger K, Tabák AG, Schloot NC, Witte DR.

Diabetes Care. 2009 Mar;32(3):421-3. Epub 2008 Dec 10.PMID: 19073760 [PubMed - indexed for MEDLINE]Related articlesFree article

Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus.

Ybarra J, Lehmann TN, Golay A, Juge-Aubry CE, Roux-Lombard P, Dayer JM, Meier CA.

Diabetes Metab. 2008 Feb;34(1):75-81. Epub 2008 Feb 1.PMID: 18243027 [PubMed - indexed for MEDLINE]Related articlesFree article

Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.

Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF.

Diabetes. 2003 Mar;52(3):812-7.PMID: 12606524 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes.

Pfleger C, Mortensen HB, Hansen L, Herder C, Roep BO, Hoey H, Aanstoot HJ, Kocova M, Schloot NC; Hvidøre Study Group on Childhood Diabetes.

Diabetes. 2008 Apr;57(4):929-37. Epub 2008 Feb 25.PMID: 18299313 [PubMed - indexed for MEDLINE]Related articlesFree article

Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

Larsen CM, Faulenbach M, Vaag A, Ehses JA, Donath MY, Mandrup-Poulsen T.

Diabetes Care. 2009 Sep;32(9):1663-8. Epub 2009 Jun 19.PMID: 19542207 [PubMed - indexed for MEDLINE]Related articles

Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.

Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, Koenig W, Herder C.

Diabetes Care. 2007 Apr;30(4):854-60.PMID: 17392546 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis.

Comabella M, Julià E, Tintoré M, Brieva L, Téllez N, Río J, López C, Rovira A, Montalban X.

J Neurol. 2008 Aug;255(8):1136-41. Epub 2008 May 20.PMID: 18484235 [PubMed - indexed for MEDLINE]Related articles

Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury.

Mandrup-Poulsen T, Wogensen LD, Jensen M, Svensson P, Nilsson P, Emdal T, Mølvig J, Dinarello CA, Nerup J.

Crit Care Med. 1995 Jan;23(1):26-33.PMID: 8001382 [PubMed - indexed for MEDLINE]Related articles

[Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy]

Zwiech R, Kacprzyk F, Szuflet A, Nowicki M.

Pol Arch Med Wewn. 2005 Apr;113(4):326-33. Polish. PMID: 16209246 [PubMed - indexed for MEDLINE]Related articles

Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males.

Ovaskainen Y, Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Vanhala M.

Psychiatry Res. 2009 May 15;167(1-2):73-9. Epub 2009 Apr 5.PMID: 19346005 [PubMed - indexed for MEDLINE]Related articles

Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).

Herder C, Kolb H, Koenig W, Haastert B, Müller-Scholze S, Rathmann W, Holle R, Thorand B, Wichmann HE.

Diabetes Care. 2006 Feb;29(2):368-71.PMID: 16443889 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002.

Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, Meisinger C, Illig T, Martin S, Herder C.

Diabetes. 2005 Oct;54(10):2932-8.PMID: 16186395 [PubMed - indexed for MEDLINE]Related articlesFree article

Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.

Sikora JP, Kuzański W, Andrzejewska E.

Med Sci Monit. 2009 Jan;15(1):CR26-31.PMID: 19114968 [PubMed - indexed for MEDLINE]Related articlesFree article

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.

Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.PMID: 11056663 [PubMed - indexed for MEDLINE]Related articlesFree article

Can the interleukin-1 receptor antagonist (IL-1ra) be a marker of anti-inflammatory response to enteral immunonutrition in malnourished patients after pancreaticoduodenectomy?

Slotwinski R, Olszewski WL, Slotkowski M, Lech G, Zaleska M, Slotwinska SM, Krasnodebski WI.

JOP. 2007 Nov 9;8(6):759-69.PMID: 17993728 [PubMed - indexed for MEDLINE]Related articlesFree article

Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984-2002.

Herder C, Baumert J, Thorand B, Koenig W, de Jager W, Meisinger C, Illig T, Martin S, Kolb H.

Diabetologia. 2006 May;49(5):921-9. Epub 2006 Mar 11.PMID: 16532324 [PubMed - indexed for MEDLINE]Related articles

Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study.

Jylhä M, Paavilainen P, Lehtimäki T, Goebeler S, Karhunen PJ, Hervonen A, Hurme M.

J Gerontol A Biol Sci Med Sci. 2007 Sep;62(9):1016-21.PMID: 17895441 [PubMed - indexed for MEDLINE]Related articles

IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?

Meier CA, Bobbioni E, Gabay C, Assimacopoulos-Jeannet F, Golay A, Dayer JM.

J Clin Endocrinol Metab. 2002 Mar;87(3):1184-8.PMID: 11889184 [PubMed - indexed for MEDLINE]Related articlesFree article

Allele 2 of interleukin-1 receptor antagonist gene increases the risk of thyroid peroxidase antibodies in subacute thyroiditis.

Luotola K, Mantula P, Salmi J, Haapala AM, Laippala P, Hurme M.

APMIS. 2001 Jun;109(6):454-60.PMID: 11506478 [PubMed - indexed for MEDLINE]Related articles

Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury.

Davies AL, Hayes KC, Dekaban GA.

Arch Phys Med Rehabil. 2007 Nov;88(11):1384-93.PMID: 17964877 [PubMed - indexed for MEDLINE]Related articles